Post My Press Release

Free Press Release Distribution

Category: Medical Industry (Page 1 of 14)

Emergency Medical Equipment Market Revenue Growth 2026

Emergency Medical Services (EMS) require specialized equipment to aid in the provision of emergency care. The rapid development of medical technology has transformed the international EMS systems with introduction of multifunctional compact monitoring systems. These equipment are making the task of monitoring patients manageable in an uncontrolled environment of pre-hospital settings.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2161

Market Dynamics

Increasing geriatric population prone to various medical emergencies such as cardiac arrest, respiratory disorders, and other medical urgency and rising incidences of natural calamities require advanced emergency medical care. According to American Heart Association 2016 report, cardiovascular disease is the leading cause of death worldwide, accounting for around 17.3 million deaths annually and is expected to reach over 23.6 million by 2030.

According to GRID-Arendal, an official United Nations Environment Programme (UNEP) 2018, with the growing population and infrastructures, the world’s exposure to natural hazards is increasing inevitably. Therefore, all these factors are collectively rising the demand for emergency medical services eventually driving the emergency medical equipment market revenue.

Despite the increasing demand, the emergency medical services varies drastically from developed to developing countries.

For instance, according to the Journal of Emergency Medical Services, in 2019, India will host the Asian Conference on Emergency Medicine, which is expected to be attended by major industry players, and India is a good entry point for the entire subcontinent.

Emergency Medical Equipment Market – Competitive Landscape

Key players operating in the global emergency medical equipment market include 3M, Abbott, Asahi Kasei Corporation, B. Braun Medical, BD, Cardinal Health, GE Healthcare, Henry Schein, Johnson & Johnson, Philips Healthcare, Smith & Nephew, and Stryker Corporation.

Request for Customized Report :https://www.coherentmarketinsights.com/insight/request-customization/2161

Detailed Segmentation:

  • Global Emergency Medical Equipment Market, By Product Type:
    • Diagnostic Medical Equipment
    • Emergency Resuscitation Equipment
    • Personal Protective Equipment
    • Patient Handling Equipment
    • Other Equipment
  • Global Emergency Medical Equipment Market, By Application:
    • Cardiac Care
    • Cancer Care
    • Respiratory Care
    • Trauma
    • Other Applications

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Global OTC Drug Market 2018 Trends, Market Share, Industry Size, Opportunities, Analysis And Forecast To 2025

OTC Drug Market 2018

Wiseguyreports.Com Adds “OTC Drug – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Description: 

This report studies the global market size of OTC Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of OTC Drug in these regions.
This research report categorizes the global OTC Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

In 2017, the global OTC Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the OTC Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of OTC Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the OTC Drug include
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3356334-global-otc-drug-market-insights-forecast-to-2025

Market Size Split by Type
Class A
Class B
Market Size Split by Application
Hospital
Clinic
Household

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3356334-global-otc-drug-market-insights-forecast-to-2025

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content:

1 Study Coverage
1.1 OTC Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global OTC Drug Market Size Growth Rate by Type
1.4.2 Class A
1.4.3 Class B
1.5 Market by Application
1.5.1 Global OTC Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global OTC Drug Market Size
2.1.1 Global OTC Drug Revenue 2016-2025
2.1.2 Global OTC Drug Sales 2016-2025
2.2 OTC Drug Growth Rate by Regions
2.2.1 Global OTC Drug Sales by Regions
2.2.2 Global OTC Drug Revenue by Regions

……..

11 Company Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of OTC Drug
11.1.4 OTC Drug Product Description
11.1.5 Recent Development
11.2 GlaxoSmithKline (GSK)
11.2.1 GlaxoSmithKline (GSK) Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of OTC Drug
11.2.4 OTC Drug Product Description
11.2.5 Recent Development
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of OTC Drug
11.3.4 OTC Drug Product Description
11.3.5 Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of OTC Drug
11.4.4 OTC Drug Product Description
11.4.5 Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of OTC Drug
11.5.4 OTC Drug Product Description
11.5.5 Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of OTC Drug
11.6.4 OTC Drug Product Description
11.6.5 Recent Development
11.7 BioGaia
11.7.1 BioGaia Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of OTC Drug
11.7.4 OTC Drug Product Description
11.7.5 Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of OTC Drug
11.8.4 OTC Drug Product Description
11.8.5 Recent Development
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of OTC Drug
11.9.4 OTC Drug Product Description
11.9.5 Recent Development
11.10 Chr. Hansen
11.10.1 Chr. Hansen Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of OTC Drug
11.10.4 OTC Drug Product Description
11.10.5 Recent Development
11.11 Cipla
11.12 CoLucid
11.13 Daiichi Sankyo
11.14 Friggs
11.15 DSM
11.16 Eisai
11.17 Eli Lilly
11.18 Herbalife
11.19 Euradite

Continued…..

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Needle Free Injection System Market 2018: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2023

Needle Free Injection System Market 2018     

Wiseguyreports.Com Adds “Needle Free Injection System – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2023” To Its Research Database.

Description: 

The Needle Free Injection System market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Needle Free Injection System industrial chain, this report mainly elaborate the definition, types, applications and major players of Needle Free Injection System market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Needle Free Injection System market.
The Needle Free Injection System market can be split based on product types, major applications, and important regions.

Major Players in Needle Free Injection System market are:
FeltonMedical
Activa
SHUCOInternational
Felton Medica
NidecTosok
Syrijet MarkIV Mizzy
Pet-O-Jet
Robbins

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3330689-global-needle-free-injection-system-industry-market-research-report

Major Regions play vital role in Needle Free Injection System market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Needle Free Injection System products covered in this report are:
Fillable
Prefilled

Most widely used downstream fields of Needle Free Injection System market covered in this report are:
Hospital
Clinic

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3330689-global-needle-free-injection-system-industry-market-research-report

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content:

Global Needle Free Injection System Industry Market Research Report
1 Needle Free Injection System Introduction and Market Overview
    1.1 Objectives of the Study
1.2 Definition of Needle Free Injection System
1.3 Needle Free Injection System Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Needle Free Injection System Value ($) and Growth Rate from 2013-2023
1.4 Market Segmentation
1.4.1 Types of Needle Free Injection System
1.4.2 Applications of Needle Free Injection System
1.4.3 Research Regions
1.4.3.1 North America Needle Free Injection System Production Value ($) and Growth Rate (2013-2018)
1.4.3.2 Europe Needle Free Injection System Production Value ($) and Growth Rate (2013-2018)
1.4.3.3 China Needle Free Injection System Production Value ($) and Growth Rate (2013-2018)
1.4.3.4 Japan Needle Free Injection System Production Value ($) and Growth Rate (2013-2018)
1.4.3.5 Middle East & Africa Needle Free Injection System Production Value ($) and Growth Rate (2013-2018)
1.4.3.6 India Needle Free Injection System Production Value ($) and Growth Rate (2013-2018)
1.4.3.7 South America Needle Free Injection System Production Value ($) and Growth Rate (2013-2018)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Needle Free Injection System
1.5.1.2 Growing Market of Needle Free Injection System
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies

……..

8 Competitive Landscape
    8.1 Competitive Profile
    8.2 FeltonMedical
      8.2.1 Company Profiles
8.2.2 Needle Free Injection System Product Introduction
8.2.3 FeltonMedical Production, Value ($), Price, Gross Margin 2013-2018E
8.2.4 FeltonMedical Market Share of Needle Free Injection System Segmented by Region in 2017
    8.3 Activa
      8.3.1 Company Profiles
8.3.2 Needle Free Injection System Product Introduction
8.3.3 Activa Production, Value ($), Price, Gross Margin 2013-2018E
8.3.4 Activa Market Share of Needle Free Injection System Segmented by Region in 2017
    8.4 SHUCOInternational
      8.4.1 Company Profiles
8.4.2 Needle Free Injection System Product Introduction
8.4.3 SHUCOInternational Production, Value ($), Price, Gross Margin 2013-2018E
8.4.4 SHUCOInternational Market Share of Needle Free Injection System Segmented by Region in 2017
    8.5 Felton Medica
      8.5.1 Company Profiles
8.5.2 Needle Free Injection System Product Introduction
8.5.3 Felton Medica Production, Value ($), Price, Gross Margin 2013-2018E
8.5.4 Felton Medica Market Share of Needle Free Injection System Segmented by Region in 2017
    8.6 NidecTosok
      8.6.1 Company Profiles
8.6.2 Needle Free Injection System Product Introduction
8.6.3 NidecTosok Production, Value ($), Price, Gross Margin 2013-2018E
8.6.4 NidecTosok Market Share of Needle Free Injection System Segmented by Region in 2017
    8.7 Syrijet MarkIV Mizzy
      8.7.1 Company Profiles
8.7.2 Needle Free Injection System Product Introduction
8.7.3 Syrijet MarkIV Mizzy Production, Value ($), Price, Gross Margin 2013-2018E
8.7.4 Syrijet MarkIV Mizzy Market Share of Needle Free Injection System Segmented by Region in 2017
    8.8 Pet-O-Jet
      8.8.1 Company Profiles
8.8.2 Needle Free Injection System Product Introduction
8.8.3 Pet-O-Jet Production, Value ($), Price, Gross Margin 2013-2018E
8.8.4 Pet-O-Jet Market Share of Needle Free Injection System Segmented by Region in 2017
    8.9 Robbins
      8.9.1 Company Profiles
8.9.2 Needle Free Injection System Product Introduction
8.9.3 Robbins Production, Value ($), Price, Gross Margin 2013-2018E
8.9.4 Robbins Market Share of Needle Free Injection System Segmented by Region in 2017

Continued…..

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Nanomedicines Market 2018: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025

Nanomedicines Market 2018

Wiseguyreports.Com Adds “Nanomedicines – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Description: 

This report focuses on the global Nanomedicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanomedicines development in United States, Europe and China.

Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
North America dominates the global market for nanomedicines due to its large population of senior citizens, leading to an increased demand for improved and efficient medications, and technological advancements in the region. Europe, followed by Asia, is expected to experience high growth rate in the next few years in global nanomedicines market. China and India are expected to be the fastest-growing nanomedicines markets in Asia. Some of the key drivers for the nanomedicines market in emerging countries are the large pool of patients, rising government funding, and increasing research and development in the field of medicine.
In 2017, the global Nanomedicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3385443-global-nanomedicines-market-size-status-and-forecast-2018-2025

Market segment by Type, the product can be split into
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others

Market segment by Application, split into
Hospitals
Clinics
Research Institute

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3385443-global-nanomedicines-market-size-status-and-forecast-2018-2025

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nanomedicines Market Size Growth Rate by Type (2013-2025)
1.4.2 Nanoparticles
1.4.3 Nanoshells
1.4.4 Nanotubes
1.4.5 Nanodevices
1.4.6 Others
1.5 Market by Application
1.5.1 Global Nanomedicines Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institute
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nanomedicines Market Size
2.2 Nanomedicines Growth Trends by Regions
2.2.1 Nanomedicines Market Size by Regions (2013-2025)
2.2.2 Nanomedicines Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

 ……..

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nanomedicines Introduction
12.1.4 Abbott Revenue in Nanomedicines Business (2013-2018)
12.1.5 Abbott Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nanomedicines Introduction
12.2.4 GE Healthcare Revenue in Nanomedicines Business (2013-2018)
12.2.5 GE Healthcare Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nanomedicines Introduction
12.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2013-2018)
12.3.5 Johnson & Johnson Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nanomedicines Introduction
12.4.4 Merck Revenue in Nanomedicines Business (2013-2018)
12.4.5 Merck Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nanomedicines Introduction
12.5.4 Pfizer Revenue in Nanomedicines Business (2013-2018)
12.5.5 Pfizer Recent Development
12.6 CombiMatrix
12.6.1 CombiMatrix Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nanomedicines Introduction
12.6.4 CombiMatrix Revenue in Nanomedicines Business (2013-2018)
12.6.5 CombiMatrix Recent Development
12.7 Celgene
12.7.1 Celgene Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nanomedicines Introduction
12.7.4 Celgene Revenue in Nanomedicines Business (2013-2018)
12.7.5 Celgene Recent Development
12.8 Mallinckrodt
12.8.1 Mallinckrodt Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nanomedicines Introduction
12.8.4 Mallinckrodt Revenue in Nanomedicines Business (2013-2018)
12.8.5 Mallinckrodt Recent Development
12.9 Sigma-Tau Pharmaceuticals
12.9.1 Sigma-Tau Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nanomedicines Introduction
12.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2013-2018)
12.9.5 Sigma-Tau Pharmaceuticals Recent Development
12.10 Teva Pharmaceutical
12.10.1 Teva Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nanomedicines Introduction
12.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2013-2018)
12.10.5 Teva Pharmaceutical Recent Development
12.11 Nanosphere
12.12 UCB SA

Continued…..

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Pain Drug Delivery Market 2018: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025

Pain Drug Delivery Market 2018

Wiseguyreports.Com Adds “Pain Drug Delivery – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Description: 

This report focuses on the global Pain Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pain Drug Delivery development in United States, Europe and China.

Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.
Drug delivery is often approached via a drug’s chemical formulation, but it may also involve medical devices or drug-device combination products.
In 2017, the global Pain Drug Delivery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Medtronic
Flowonix Medical
Aveva Drug Delivery Systems
Prosolus Pharmaceuticals
Teva Pharmaceutical Industries 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3372397-global-pain-drug-delivery-market-size-status-and-forecast-2018-2025

Market segment by Type, the product can be split into
Transdermal Drug Delivery System
Intrathecal Drug Delivery System
Others

Market segment by Application, split into
Oncology
Neurological Disorders
Pulmonary Diseases
Hormonal Disorders
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3372397-global-pain-drug-delivery-market-size-status-and-forecast-2018-2025

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pain Drug Delivery Market Size Growth Rate by Type (2013-2025)
1.4.2 Transdermal Drug Delivery System
1.4.3 Intrathecal Drug Delivery System
1.4.4 Others
1.5 Market by Application
1.5.1 Global Pain Drug Delivery Market Share by Application (2013-2025)
1.5.2 Oncology
1.5.3 Neurological Disorders
1.5.4 Pulmonary Diseases
1.5.5 Hormonal Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pain Drug Delivery Market Size
2.2 Pain Drug Delivery Growth Trends by Regions
2.2.1 Pain Drug Delivery Market Size by Regions (2013-2025)
2.2.2 Pain Drug Delivery Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

 ……..

12 International Players Profiles
12.1 Medtronic
12.1.1 Medtronic Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pain Drug Delivery Introduction
12.1.4 Medtronic Revenue in Pain Drug Delivery Business (2013-2018)
12.1.5 Medtronic Recent Development
12.2 Flowonix Medical
12.2.1 Flowonix Medical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pain Drug Delivery Introduction
12.2.4 Flowonix Medical Revenue in Pain Drug Delivery Business (2013-2018)
12.2.5 Flowonix Medical Recent Development
12.3 Aveva Drug Delivery Systems
12.3.1 Aveva Drug Delivery Systems Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pain Drug Delivery Introduction
12.3.4 Aveva Drug Delivery Systems Revenue in Pain Drug Delivery Business (2013-2018)
12.3.5 Aveva Drug Delivery Systems Recent Development
12.4 Prosolus Pharmaceuticals
12.4.1 Prosolus Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pain Drug Delivery Introduction
12.4.4 Prosolus Pharmaceuticals Revenue in Pain Drug Delivery Business (2013-2018)
12.4.5 Prosolus Pharmaceuticals Recent Development
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pain Drug Delivery Introduction
12.5.4 Teva Pharmaceutical Industries Revenue in Pain Drug Delivery Business (2013-2018)
12.5.5 Teva Pharmaceutical Industries Recent Development

Continued…..

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Medical connectors Market Global Sales, Revenue, Price and Gross Margin Forecast To 2023

Market Scenario:

Medical connectors are used to interconnect different medical electronic equipment, such as diagnostic devices, surgical instruments, therapy applications, surgery assist devices, and disposable equipment with one another. The global medical connector market is projected to expand at a CAGR of 8 % between the forecast period of 2017 and 2023.

The medical connectors market is growing rapidly across the world. This rapidly evolving market and emergence of numerous market suppliers are providing smaller, lighter, higher-speed, and higher-density medical connectors capable of handling big data, meeting cost targets, and others. It is widely used for industrial application which includes controls systems, industrial electronics, measurement applications and others. These connector offers flex circuits, display screens, flex switches, sensors, catheters, antennas, and integrated assemblies into their portfolios. These connectors also offer low voltage, high voltage, hybrids, intelligent technology, low cost and others, are the driving factor of the market growth. It can resist in harsh environments, contaminants, and can handle electro/mechanical pressure. It offers the highest dependability and corrosion resistance.

The medical connectors are best fitted for steam sterilization, and for disposable applications. In reusable and disposable applications, the medical connector delivers a high performance, cost-effective and best quality solutions. The medical industry has some of the most demanding applications and environments. The companies are taking interest in manufacturing safety medical connector products which can be used for test and measurement and recognizing the specific requirements of the medical industry. In medical industry, it is widely used in applications which includes X-Ray, neuro therapy, laser, noninvasive medical therapy, transcranial magnetic stimulation, instrumentation, electro surgery and others.

Key Players:

Market Research Future (MRFR) recognizes the following companies as the key players in the global medical connector market: – ITT Corporation (U.S.), Smiths Interconnect (U.K.), TE Connectivity Ltd. (Switzerland), Amphenol Corporation (U.S.), Delphi Automotive LLP. (U.K.), Esterline Corporation (U.S.), Fisher Connectors (Switzerland), Molex (U.S.), Samtec (U.S.) Lemo S.A. (Switzerland), and among others.

Get Sample of Report @ https://www.marketresearchfuture.com/sample_request/4271

Segmentation:

By application segment, the medical connector market is driven by advanced medical connector which offers quick mating, keying, vibration resist, enduring high-temp and pressure, chemical resist, and others. In medical industry, it has huge demand ranging from patient monitoring device to disposable surgical ablation catheters. These connectors are more reliable, cost-effective, low-weight designs and eliminate the potential for user fault. For instance, in medical applications where spill prevention is desired, these connectors are one of the better for them.

By Region, MRFR analysis shows that the comprehensive understanding of market dynamics, the global medical connector market is analyzed across key geographies namely North America, Europe, China, Japan, India and among others. The connectors in medical applications feature a push-pull locking mechanism that prevents accidental disconnection and others which is widely used in the medical connector market in North America region. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

The global medical connector market is bifurcated into material, connector size and region. The material includes metal, plastic and others. The region includes North America, Europe, Asia Pacific and rest of the world.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Regional Analysis:

The regional analysis of medical connector market is being studied for region such as Asia pacific, North America, Europe and Rest of the World. North America is one of the leading regions across the world in terms of largest market share in medical connectors market owing to the company’s investments in the medical applications which can be used in dental tools, electro surgery tools, catheters, sensors, respirators, ECG devices, defibrillators and others. The medical connector market in Europe region is expected to witness rapid growth in the forthcoming period. Whereas, Asia-Pacific countries like China, Japan and India is an emerging market for medical connectors market and expected to be the highest CAGR in the coming years.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

1.1 INTRODUCTION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS

1.2.3 LIMITATIONS

Continued…

LIST OF TABLES

TABLE 1 MEDICAL CONNECTOR MARKET, BY MATERIAL

TABLE 2 MEDICAL CONNECTOR MARKET, BY CONNECTOR SIZE

TABLE 3 MEDICAL CONNECTOR MARKET, BY REGIONS

Continued…

Access Report Details @ https://www.marketresearchfuture.com/reports/medical-connector-market-4271

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY

FIGURE 2 MEDICAL CONNECTOR MARKET: BY MATERIAL (%)

FIGURE 3 MEDICAL CONNECTOR MARKET: BY CONNECTOR SIZE (%)

Continued…

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Anti-Viral Drugs Market 2018: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2023

Anti-Viral Drugs Market 2018    

Wiseguyreports.Com Adds “Anti-Viral Drugs – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2023” To Its Research Database.

Description: 

The Anti-Viral Drugs market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Anti-Viral Drugs industrial chain, this report mainly elaborate the definition, types, applications and major players of Anti-Viral Drugs market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Anti-Viral Drugs market.
The Anti-Viral Drugs market can be split based on product types, major applications, and important regions.

Major Players in Anti-Viral Drugs market are:
GlaxoSmithKline
Roche
Abbott
Gilead
Johnson & Johnson
Merck & Co
Schering-Plough
Cipla
Bristol-Myers-Squibb
AstraZeneca

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3330661-global-anti-viral-drugs-industry-market-research-report

Major Regions play vital role in Anti-Viral Drugs market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Anti-Viral Drugs products covered in this report are:
Hepatitis-C Antivirals
HIV Antivirals
Herpes Antivirals
Hepatitis-B Antivirals
Influenza Antivirals
Others (Pneumonia, Flu, etc.)

Most widely used downstream fields of Anti-Viral Drugs market covered in this report are:
Hospitals
Clinics
Ambulatory Surgical Centers

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3330661-global-anti-viral-drugs-industry-market-research-report

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content:

Global Anti-Viral Drugs Industry Market Research Report
1 Anti-Viral Drugs Introduction and Market Overview
    1.1 Objectives of the Study
1.2 Definition of Anti-Viral Drugs
1.3 Anti-Viral Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Anti-Viral Drugs Value ($) and Growth Rate from 2013-2023
1.4 Market Segmentation
1.4.1 Types of Anti-Viral Drugs
1.4.2 Applications of Anti-Viral Drugs
1.4.3 Research Regions
1.4.3.1 North America Anti-Viral Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.2 Europe Anti-Viral Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.3 China Anti-Viral Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.4 Japan Anti-Viral Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.5 Middle East & Africa Anti-Viral Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.6 India Anti-Viral Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.7 South America Anti-Viral Drugs Production Value ($) and Growth Rate (2013-2018)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Anti-Viral Drugs
1.5.1.2 Growing Market of Anti-Viral Drugs
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies

…….

8 Competitive Landscape
    8.1 Competitive Profile
    8.2 GlaxoSmithKline
      8.2.1 Company Profiles
8.2.2 Anti-Viral Drugs Product Introduction
8.2.3 GlaxoSmithKline Production, Value ($), Price, Gross Margin 2013-2018E
8.2.4 GlaxoSmithKline Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.3 Roche
      8.3.1 Company Profiles
8.3.2 Anti-Viral Drugs Product Introduction
8.3.3 Roche Production, Value ($), Price, Gross Margin 2013-2018E
8.3.4 Roche Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.4 Abbott
      8.4.1 Company Profiles
8.4.2 Anti-Viral Drugs Product Introduction
8.4.3 Abbott Production, Value ($), Price, Gross Margin 2013-2018E
8.4.4 Abbott Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.5 Gilead
      8.5.1 Company Profiles
8.5.2 Anti-Viral Drugs Product Introduction
8.5.3 Gilead Production, Value ($), Price, Gross Margin 2013-2018E
8.5.4 Gilead Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.6 Johnson & Johnson
      8.6.1 Company Profiles
8.6.2 Anti-Viral Drugs Product Introduction
8.6.3 Johnson & Johnson Production, Value ($), Price, Gross Margin 2013-2018E
8.6.4 Johnson & Johnson Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.7 Merck & Co
      8.7.1 Company Profiles
8.7.2 Anti-Viral Drugs Product Introduction
8.7.3 Merck & Co Production, Value ($), Price, Gross Margin 2013-2018E
8.7.4 Merck & Co Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.8 Schering-Plough
      8.8.1 Company Profiles
8.8.2 Anti-Viral Drugs Product Introduction
8.8.3 Schering-Plough Production, Value ($), Price, Gross Margin 2013-2018E
8.8.4 Schering-Plough Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.9 Cipla
      8.9.1 Company Profiles
8.9.2 Anti-Viral Drugs Product Introduction
8.9.3 Cipla Production, Value ($), Price, Gross Margin 2013-2018E
8.9.4 Cipla Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.10 Bristol-Myers-Squibb
      8.10.1 Company Profiles
8.10.2 Anti-Viral Drugs Product Introduction
8.10.3 Bristol-Myers-Squibb Production, Value ($), Price, Gross Margin 2013-2018E
8.10.4 Bristol-Myers-Squibb Market Share of Anti-Viral Drugs Segmented by Region in 2017
    8.11 AstraZeneca
      8.11.1 Company Profiles
8.11.2 Anti-Viral Drugs Product Introduction
8.11.3 AstraZeneca Production, Value ($), Price, Gross Margin 2013-2018E
8.11.4 AstraZeneca Market Share of Anti-Viral Drugs Segmented by Region in 2017

Continued…..

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Disposable Sterile Syringes and Needles Market 2018: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025

Disposable Sterile Syringes and Needles Market 2018 

Wiseguyreports.Com Adds “Disposable Sterile Syringes and Needles – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Description: 

This report studies the global Disposable Sterile Syringes and Needles market status and forecast, categorizes the global Disposable Sterile Syringes and Needles market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Disposable Sterile Syringes and Needles market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report
Becton Dickinson and Company
Bayer
Smiths Medical ASD,Inc
Feel Tech
B.Braun Melsungen AG,OPM
Owen Mumford Limited
Medexel Co., Ltd
Terumo
HTL-Strefa S.A.
Ypsomed AG
OASIS Medical, Inc
Alcon Laboratories Incorporated
Twobiens Co.,Ltd
Parker Dayton Technology Suzhou Co., Ltd.
Light Medical Products Co., Ltd.
Tonghua Dongbao Pharmaceutical Co., Ltd.
COVIDIEN
Medtronic
Merit Medical Systems
Nipro
HENKE SASS WOLF
Imaxeon Pty Ltd

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3312433-global-disposable-sterile-syringes-and-needles-market-research-report-2018

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Syringes
Needles
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital
Lab
Home
Other

Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/3312433-global-disposable-sterile-syringes-and-needles-market-research-report-2018

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content:

Global Disposable Sterile Syringes and Needles Market Research Report 2018
1 Disposable Sterile Syringes and Needles Market Overview
1.1 Product Overview and Scope of Disposable Sterile Syringes and Needles
1.2 Disposable Sterile Syringes and Needles Segment by Type (Product Category)
1.2.1 Global Disposable Sterile Syringes and Needles Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Disposable Sterile Syringes and Needles Production Market Share by Type (Product Category) in 2017
1.2.3 Syringes
1.2.4 Needles
1.3 Global Disposable Sterile Syringes and Needles Segment by Application
1.3.1 Disposable Sterile Syringes and Needles Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Lab
1.3.4 Home
1.3.5 Other
1.4 Global Disposable Sterile Syringes and Needles Market by Region (2013-2025)
1.4.1 Global Disposable Sterile Syringes and Needles Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Disposable Sterile Syringes and Needles (2013-2025)
1.5.1 Global Disposable Sterile Syringes and Needles Revenue Status and Outlook (2013-2025)
1.5.2 Global Disposable Sterile Syringes and Needles Capacity, Production Status and Outlook (2013-2025)

…….

7 Global Disposable Sterile Syringes and Needles Manufacturers Profiles/Analysis
7.1 Becton Dickinson and Company
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Becton Dickinson and Company Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bayer
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bayer Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Smiths Medical ASD,Inc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Smiths Medical ASD,Inc Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Feel Tech
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Feel Tech Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 B.Braun Melsungen AG,OPM
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 B.Braun Melsungen AG,OPM Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Owen Mumford Limited
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Owen Mumford Limited Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Medexel Co., Ltd
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Medexel Co., Ltd Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Terumo
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Terumo Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 HTL-Strefa S.A.
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 HTL-Strefa S.A. Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Ypsomed AG
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Disposable Sterile Syringes and Needles Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Ypsomed AG Disposable Sterile Syringes and Needles Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 OASIS Medical, Inc
7.12 Alcon Laboratories Incorporated
7.13 Twobiens Co.,Ltd
7.14 Parker Dayton Technology Suzhou Co., Ltd.
7.15 Light Medical Products Co., Ltd.
7.16 Tonghua Dongbao Pharmaceutical Co., Ltd.
7.17 COVIDIEN
(Medtronic
7.18 Merit Medical Systems
7.19 Nipro
7.20 HENKE SASS WOLF
7.21 Imaxeon Pty Ltd

Continued…..

Contact US:                        

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Page 1 of 14

Powered by WordPress & Theme by Anders Norén